UnitedHealth Group (NYSE:UNH) Releases FY 2025 Earnings Guidance

UnitedHealth Group (NYSE:UNH - Get Free Report) issued an update on its FY 2025 earnings guidance on Thursday morning. The company provided earnings per share guidance of 26.000-26.500 for the period, compared to the consensus earnings per share estimate of 29.730. The company issued revenue guidance of -, compared to the consensus revenue estimate of $452.3 billion.

Analyst Upgrades and Downgrades

Several analysts have commented on UNH shares. Truist Financial dropped their target price on shares of UnitedHealth Group from $660.00 to $580.00 and set a "buy" rating for the company in a research report on Monday. Argus lowered shares of UnitedHealth Group from a "buy" rating to a "hold" rating in a research note on Monday. Oppenheimer reduced their price target on shares of UnitedHealth Group from $640.00 to $600.00 and set an "outperform" rating on the stock in a research report on Monday. Barclays cut their price objective on UnitedHealth Group from $642.00 to $560.00 and set an "overweight" rating on the stock in a report on Monday. Finally, KeyCorp lowered their price objective on shares of UnitedHealth Group from $650.00 to $575.00 and set an "overweight" rating on the stock in a report on Monday. One analyst has rated the stock with a hold rating, twenty have given a buy rating and four have given a strong buy rating to the company. Based on data from MarketBeat, the stock presently has a consensus rating of "Buy" and a consensus target price of $615.24.

UnitedHealth Group Trading Down 5.1 %

NYSE UNH traded down $23.17 during mid-day trading on Monday, reaching $430.94. 6,781,725 shares of the stock were exchanged, compared to its average volume of 4,375,469. The company has a debt-to-equity ratio of 0.74, a current ratio of 0.83 and a quick ratio of 0.91. The stock has a 50 day simple moving average of $512.95 and a 200-day simple moving average of $539.93. UnitedHealth Group has a one year low of $427.21 and a one year high of $630.73. The stock has a market cap of $394.19 billion, a P/E ratio of 27.80, a P/E/G ratio of 1.37 and a beta of 0.61.

UnitedHealth Group (NYSE:UNH - Get Free Report) last issued its quarterly earnings results on Thursday, April 17th. The healthcare conglomerate reported $7.20 earnings per share (EPS) for the quarter, missing the consensus estimate of $7.29 by ($0.09). UnitedHealth Group had a net margin of 3.60% and a return on equity of 26.69%. The business had revenue of $109.58 billion during the quarter, compared to analyst estimates of $111.56 billion. During the same period last year, the firm posted $6.91 earnings per share. On average, analysts anticipate that UnitedHealth Group will post 29.54 EPS for the current year.

UnitedHealth Group Announces Dividend

The company also recently announced a quarterly dividend, which was paid on Tuesday, March 18th. Investors of record on Monday, March 10th were given a $2.10 dividend. This represents a $8.40 dividend on an annualized basis and a yield of 1.95%. The ex-dividend date was Monday, March 10th. UnitedHealth Group's payout ratio is 54.19%.

Hedge Funds Weigh In On UnitedHealth Group

An institutional investor recently raised its position in UnitedHealth Group stock. Brighton Jones LLC lifted its position in shares of UnitedHealth Group Incorporated (NYSE:UNH - Free Report) by 176.2% during the fourth quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The institutional investor owned 44,249 shares of the healthcare conglomerate's stock after purchasing an additional 28,231 shares during the period. UnitedHealth Group accounts for about 0.6% of Brighton Jones LLC's holdings, making the stock its 24th biggest position. Brighton Jones LLC's holdings in UnitedHealth Group were worth $22,384,000 at the end of the most recent reporting period. 87.86% of the stock is currently owned by institutional investors and hedge funds.

About UnitedHealth Group

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.